MLTX
MoonLake Immunotherapeutics
11.40$
-0.5%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | – | – | – | – | – | |
| – | – | +148.6% | +6.5% | +10,423.9% | +88.9% | |
| – | – | – | – | – | – | |
| – | – | +18.4% | -24.4% | +254.6% | +79.9% | |
| – | – | +403.5% | -3.0% | +35.8% | +38.4% | |
| – | +4,221.6% | +1,323.6% | -16.8% | +164.4% | +69.3% | |
| – | – | – | – | – | – | |
| – | – | – | -100.0% | – | – | |
| – | – | – | – | – | – | |
| – | – | +537.3% | +159.6% | +199.0% | +116.5% | |
| – | – | – | – | – | – | |
| – | – | – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.